Comparison of age-related macular degeneration treatment trials: what did we learn?
作者信息
Csaky Karl G
出版信息
Retina. 2012 Mar;32(3):413-6. doi: 10.1097/IAE.0B013E3182493C05.
PMID:22374153
Abstract
摘要
相似文献
1
Comparison of age-related macular degeneration treatment trials: what did we learn?年龄相关性黄斑变性治疗试验的比较：我们学到了什么？
Retina. 2012 Mar;32(3):413-6. doi: 10.1097/IAE.0B013E3182493C05.
2
[Bevacizumab versus ranibizumab: a draw?].
J Fr Ophtalmol. 2012 Feb;35(2):79-81. doi: 10.1016/j.jfo.2011.06.003. Epub 2011 Oct 26.
3
Comparison of age-related macular degeneration treatment trial.年龄相关性黄斑变性治疗试验的比较。
Insight. 2011 Summer;36(3):20.
4
[Antiangiogenic agents in ARMD treatment].
Oftalmologia. 2012;56(1):51-7.
5
Preferred therapies for neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性的首选治疗方法。
Curr Opin Ophthalmol. 2011 May;22(3):199-204. doi: 10.1097/ICU.0b013e32834597d9.
6
Microperimetric changes after intravitreal bevacizumab for exudative age-related macular degeneration.玻璃体内注射贝伐单抗治疗渗出性年龄相关性黄斑变性后的微视野变化
Acta Ophthalmol. 2008 Sep;86(6):696-7. doi: 10.1111/j.1600-0420.2007.01131.x.
7
Comparing ranibizumab with bevacizumab.雷珠单抗与贝伐单抗的比较。
Ophthalmology. 2011 Mar;118(3):600-600.e2. doi: 10.1016/j.ophtha.2010.10.027.
8
Intersession repeatability of visual acuity scores in age-related macular degeneration.年龄相关性黄斑变性患者视力评分的学期间重复性
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4347-52. doi: 10.1167/iovs.08-1935. Epub 2008 Jun 19.
9
Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.玻璃体内注射贝伐单抗治疗渗出性年龄相关性黄斑变性所致视乳头旁脉络膜新生血管
Acta Ophthalmol. 2011 Feb;89(1):e105-7. doi: 10.1111/j.1755-3768.2009.01820.x.
10
Implications of "not me" drugs for health systems: lessons from age related macular degeneration.“非我”类药物对卫生系统的影响：年龄相关性黄斑变性的经验教训
BMJ. 2012 May 1;344:e2941. doi: 10.1136/bmj.e2941.
引用本文的文献
1
Mechanism of inflammation in age-related macular degeneration.年龄相关性黄斑变性的炎症机制。
Mediators Inflamm. 2012;2012:546786. doi: 10.1155/2012/546786. Epub 2012 Nov 7.
Zotero 插件